# Individualizing Antidepressant Treatment Using Pharmacogenomics and EHR-driven Clinical Decision Support

> **NCT03952494** · NA · WITHDRAWN · sponsor: **Weill Medical College of Cornell University**

## Conditions studied

- Depression

## Interventions

- **GENETIC:** Genomind®Professional PGx Express TM

## Key facts

- **NCT ID:** NCT03952494
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-03-01
- **Primary completion:** 2023-02-28
- **Final completion:** 2023-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due to some administrative issues, the study had to be stopped. There were 0 subjects enrolled.
- **Last updated:** 2021-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03952494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03952494, "Individualizing Antidepressant Treatment Using Pharmacogenomics and EHR-driven Clinical Decision Support". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT03952494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*